Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 3/20 | 0.45 |
| ▸ | POLB | P06746 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 4/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA3 | P07451 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | CA6 | P23280 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2825786 | 0.80 | ALDH1A1 (0.62) | GAAPOLBLMNAL3MBTL1KDM4E | |
| SCHEMBL19119211 | 0.80 | POLB (0.59) | SMN1; SMN2GAAPOLBLMNAL3MBTL1 | |
| SCHEMBL27349927 | 0.79 | LMNA (0.46) | SMN1; SMN2GAAPOLBLMNAL3MBTL1 | |
| SCHEMBL30602792 | 0.79 | LMNA (0.45) | SMN1; SMN2GAAPOLBLMNAL3MBTL1 | |
| SCHEMBL13543494 | 0.79 | CYP3A4 (0.52) | SMN1; SMN2GAAPOLBLMNAL3MBTL1 | |
| SCHEMBL4844487 | 0.79 | KMT2A (0.50) | SMN1; SMN2GAAPOLBLMNAL3MBTL1 | |
| SCHEMBL29602365 | 0.79 | CYP3A4 (0.52) | SMN1; SMN2GAAPOLBLMNAL3MBTL1 | |
| SCHEMBL3920308 | 0.79 | LMNA (0.68) | SMN1; SMN2GAALMNAL3MBTL1MEN1 | |
| SCHEMBL12225751 | 0.79 | HSD17B10 (0.54) | SMN1; SMN2GAAPOLBLMNAL3MBTL1 | |
| SCHEMBL14190056 | 0.79 | LMNA (0.45) | SMN1; SMN2GAAPOLBLMNAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180001603-A1 | Sulfonylazide Derivative for Tie Layer | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-01-04 | — | — | US | disclosed |
| US-20170190823-A1 | Sulfonylazide Derivative for Diene Polymer | DOW GLOBAL TECHNOLOGIES LLC | 2017-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170190823-A1 | Sulfonylazide Derivative for Diene Polymer | SSTR4, SALL4, DPP4 | SMN1; SMN2 433/4885GAA 309/4885POLB 3299/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.